Natixis Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196M | Sell |
|
|||||
|
2025
Q1 | $202M | Sell |
|
|||||
|
2024
Q4 | $260M | Sell |
|
|||||
|
2024
Q3 | $366M | Buy |
|
|||||
|
2024
Q2 | $427M | Buy |
|
|||||
|
2024
Q1 | $384M | Sell |
|
|||||
|
2023
Q4 | $316M | Buy |
|
|||||
|
2023
Q3 | $273M | Sell |
|
|||||
|
2023
Q2 | $247M | Buy |
|
|||||
|
2023
Q1 | $240M | Buy |
|
|||||
|
2022
Q4 | $197M | Sell |
|
|||||
|
2022
Q3 | $148M | Buy |
|
|||||
|
2022
Q2 | $157M | Buy |
|
|||||
|
2022
Q1 | $134M | Buy |
|
|||||
|
2021
Q4 | $114M | Sell |
|
|||||
|
2021
Q3 | $124M | Buy |
|
|||||
|
2021
Q2 | $81.8M | Sell |
|
|||||
|
2021
Q1 | $67M | Buy |
|
|||||
|
2020
Q4 | $64.9M | Sell |
|
|||||
|
2020
Q3 | $72.9M | Sell |
|
|||||
|
2020
Q2 | $70.3M | Sell |
|
|||||
|
2020
Q1 | $91.1M | Sell |
|
|||||
|
2019
Q4 | $99.1M | Sell |
|
|||||
|
2019
Q3 | $92M | Sell |
|
|||||
|
2019
Q2 | $94.3M | Buy |
|
|||||
|
2019
Q1 | $96.4M | Buy |
|
|||||
|
2018
Q4 | $82.1M | Buy |
|
|||||
|
2018
Q3 | $83.9M | Buy |
|
|||||
|
2018
Q2 | $70.6M | Sell |
|
|||||
|
2018
Q1 | $85.6M | Sell |
|
|||||
|
2017
Q4 | $94.6M | Buy |
|
|||||
|
2017
Q3 | $82.3M | Buy |
|
|||||
|
2017
Q2 | $66.3M | Buy |
|
|||||
|
2017
Q1 | $51.5M | Buy |
|
|||||
|
2016
Q4 | $42.5M | Buy |
|
|||||
|
2016
Q3 | $41.7M | Buy |
|
|||||
|
2016
Q2 | $48.6M | Buy |
|
|||||
|
2016
Q1 | $47.9M | Buy |
|
|||||
|
2015
Q4 | $47.8M | Buy |
|
|||||
|
2015
Q3 | $44.3M | Buy |
|
|||||
|
2015
Q2 | $38.6M | Buy |
|
|||||
|
2015
Q1 | $33.1M | Buy |
|
|||||
|
2014
Q4 | $20.5M | Buy |
|
|||||
|
2014
Q3 | $17.2M | Sell |
|
|||||
|
2014
Q2 | $27.2M | Buy |
|
|||||
|
2014
Q1 | $25.2M | Buy |
|
|||||
|
2013
Q4 | $1.5M | Sell |
|
|||||
|
2013
Q3 | $7.27M | Buy |
|
|||||
|
2013
Q2 | $6.47M | Buy |
|